News In Brief
This article was originally published in The Gray Sheet
Bypass surgery beats coronary intervention in multivessel disease patients. Medical device excise tax repeal efforts criticized in NEJM commentary. More news.
You may also be interested in...
The 2014 federal budget request submitted by President Obama April 10 includes proposals to cut clinical lab services and to limit Medicaid reimbursement for durable medical equipment, among other cuts that would affect the medtech industry.
BD gained FDA approval for the first in a line of prefilled generic injectable drugs that will be marketed by its new subsidiary, BD Rx.
CMS is unlikely to consider national coverage of radiation therapy for prostate cancer anytime soon because of insufficient evidence on the effectiveness of the treatment, according to Marcel Salive, director of medical and surgical services in CMS' Coverage and Analysis Group